Personalized Medicine: Consumer Concerns About Coverage, Affordability and Privacy
Health Populi
MAY 30, 2018
This is important because in 2017, one in four new drugs approved by the FDA were designed to treat a small population, falling. An essay in Health Affairs speaks to Data Sharing For Precision Medicine: Policy Lessons and Future Directions, written by a team of researchers based in Zurich a the Swiss Federal Institute of Technology (ETH).
Let's personalize your content